The Food and Drug Administration is promoting Namandjé Bumpus to principal deputy commissioner upon the retirement of Janet Woodcock early next year. Bumpus joined the FDA in August 2022 to serve as the agency’s chief scientist. Michael Rogers has been named associate commissioner for regulatory affairs.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
